Home -> Law Blog Directory -> Personal Injury Law Blogs -> Tampa Bay Personal Injury Law
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: Tampa Bay Personal Injury Law4 Popular Drugs Get Stronger Warnings Due to Risk of Fungal Infections
By Joe Saunders
The FDA has ordered stronger warning labels for 4 drugs that treat arthritis and Crohn's disease. The Food and Drug Administration ordered stronger warning labels for Johnson & Johnson's Remicade; Abbott Laboratories' Humira; Enbrel, from Amgen Inc. and Wyeth; and UCB SA's Cimzia.
The drugs belong to a specific class of drugs known as TNF (tumor necrosis factor) blockers. The drugs target the overproduction of TNF in patients suffering from arthritis and Crohn's but in so doing, lower the body's immune system. According to a report in the Wall St. Journal, "the FDA said it reviewed 240 reports of histoplasmosis, a particularly invasive respiratory disease with symptoms similar to the flu, in patients being treated with Enbrel, Humira, or Remicade. The FDA found one case of the disease in a patient taking Cimzia."
Originally posted at InjuryBoard by Joe SaundersFull post as published by Tampa Bay Personal Injury Law on September 05, 2008 (boomark / email).
Darvon
Other Propoxyphene-Containing Meds to Require Stronger Warnings
ETHEX Corp
5 Generic Drugs Recalled Due to Risk of Death From Overdose
Cipro
The FDA is seeking to add black box warnings of the risk of tendon rupture associated with Cipro and Levaquin.
The ruptures can involve Achilles tendon, shoulder, hand, bicep or thumb tendons, and is especially increased in patients older than 60, or people who have received kidney, heart or lung transplants, as well as people on steroid therapy...
Popular, Inc.
BPOP
Popular, Inc.
401(k) / ERISA Stock Fraud
Acetaminophen
FDA Wants New Safety Warnings

F.D.A. Orders Stronger Warnings on Arthritis Drugs
Stronger Warnings Ordered for Arthritis Drugs
FDA Adds Warnings on Arthritis Drugs
Anemia Drugs Given Stronger Warnings
Tendinitis and Tendon Rupture Lead to Black Box Warning







